{
    "2021-10-27": [
        [
            {
                "time": "2023-10-10",
                "original_text": "金域医学：股东君睿祺及君联茂林减持72万股公司股份 减持股份数量",
                "features": {
                    "keywords": [
                        "金域医学",
                        "股东",
                        "君睿祺",
                        "君联茂林",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "诊断服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "太平洋：给予金域医学买入评级，目标价位177.0元",
                "features": {
                    "keywords": [
                        "太平洋",
                        "金域医学",
                        "买入评级",
                        "目标价"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "诊断服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "朝闻国盛：北上连续流入破百亿",
                "features": {
                    "keywords": [
                        "北上资金",
                        "流入",
                        "百亿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "中泰证券给予金域医学买入评级：常规业务加速恢复，新冠检测持续放量",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "金域医学",
                        "买入评级",
                        "常规业务",
                        "新冠检测",
                        "放量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "诊断服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "中泰证券：给予金域医学买入评级",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "金域医学",
                        "买入评级"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "诊断服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "西部证券给予金域医学买入评级：常规业务高质量发展，新冠业务持续放量",
                "features": {
                    "keywords": [
                        "西部证券",
                        "金域医学",
                        "买入评级",
                        "常规业务",
                        "新冠业务",
                        "放量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "诊断服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "医学诊断业务创新高 被MSCI ESG评为AA级",
                "features": {
                    "keywords": [
                        "医学诊断",
                        "创新高",
                        "MSCI",
                        "ESG",
                        "AA级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "诊断服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}